You are here: Industry Insights > SARS-CoV-2

News List

Scientists identified vulnerable site on multiple coronaviruses WorldPharmaNews
February 11, 2022
The COVID-causing virus SARS-CoV-2 harbors a vulnerable site at the base of its spike protein that is found also on closely related coronaviruses, according to a new study from Scripps Research.
New antiviral drug combo highly effective against coronavirus: Study ExpressPharma
February 11, 2022
The research, published recently in the journal Nature, suggests that these drugs are more potent when used in combination than individually.
Plant “biofactories” produce proteins for potential COVID-19 vaccine EuropeanPharmaceuticalReview
February 10, 2022
COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 replicates by infecting human cells via the interaction of the receptor-binding domain (RBD) on the viral Spike (S) protein...
COVID-19 Convalescent Plasma Seems Safe for High-Risk Children drugs.com
February 08, 2022
High-titer COVID-19 convalescent plasma seems safe when given to high-risk children, but recipient plasma neutralization...
Model Medicines Reports Positive Results for Anti-COVID-19 Drug Candidate contractpharma
February 08, 2022
Model Medicines Reports Positive Results for Anti-COVID-19 Drug Candidate.
Three exposures to spike protein allow people to develop broad antibody immunity - also against Omicron WorldPharmaNews
February 07, 2022
Scientists from Ludwig-Maximilians-Universitaet (LMU) in Munich, Helmholtz Munich, and Technical University of Munich have shown that the immune system is capable of neutralizing even Omicron after a total of three exposures to the viral spike protein.
Compound in the herb rosemary may be useful against COVID-19 and other inflammatory diseases WorldPharmaNews
February 07, 2022
A team co-led by scientists at Scripps Research has found evidence that a compound contained in the medicinal and culinary herb rosemary could be a two-pronged weapon against the SARS-CoV-2 coronavirus that causes COVID-19.
Current COVID-19 vaccines induce robust cellular immunity against Omicron variant WorldPharmaNews
February 07, 2022
A highly mutated version of SARS-CoV-2, the virus that causes COVID-19, the Omicron variant has been shown to cause breakthrough infections among the vaccinated thanks to its ability...
COVID Infection May Boost Antibodies for Up to 20 Months drugs.com
February 07, 2022
If you've already had COVID-19, your natural antibodies may last as long as 20 months, a new study suggests.
COVID Cases Surge Once Again Amidst a Lack of Diagnostic Supplies prnewswire
January 29, 2022
The pandemic remains a major concern around the world. According to recent data published by Johns Hopkins University's Center for Systems Science and Engineering, more than 5.6 million people have died from the disease worldwide...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page